Paid Clinical Trials in South Weymouth, MA
As of August 2026, 17 paid clinical trials are recruiting in South Weymouth, Massachusetts. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
South Weymouth offers studies at sites including Dana-Farber/Brigham and Women's Cancer Center at South Shore for conditions such as Breast Cancer, Stage IIIB Lung Cancer AJCC v8, Triple Negative Breast Cancer, Advanced Esophageal Adenocarcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in South Weymouth
Trials by drug in South Weymouth
Filter results
17 clinical trials
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Zanubrutinib and Venetoclax in CLL (ZANU-VEN)
Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial
Top Research Study Locations in South Weymouth
Researchers run research studies in South Weymouth, MA at 7 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Dana-Farber/Brigham and Women's Cancer Center at South Shore | Stage IIIB Lung Cancer AJCC v8, Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma | 10 |
| Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) in Clinical Affiliation with South Shore Hospital | Breast Cancer, Triple Negative Breast Cancer | 2 |
| DF/BWCC in Clinical Affiliation with South Shore Hospital | Breast Cancer, PD-L1 Negative, Triple Negative Breast Cancer | 1 |
| Dana-Farber Brigham Cancer Center at South Shore Health | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Dana-Farber Brigham Cancer Center, South Shore Hospital | Glioblastoma (GBM) | 1 |
| Dana-Farber Cancer Institute South Shore | EGFR Gene Mutation, Lung Cancer | 1 |
| South Shore Hospital | Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) | 1 |
Active & Upcoming Studies in South Weymouth (2026)
Recruiting trials in South Weymouth grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (16 active studies)
- EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations · Dana-Farber Cancer Institute
- Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer · Phase 3 · Alliance for Clinical Trials in Oncology
Common conditions studied in South Weymouth
- Breast Cancer (3 active studies)
- Stage IIIB Lung Cancer AJCC v8 (2 active studies)
- Triple Negative Breast Cancer (2 active studies)
- Advanced Esophageal Adenocarcinoma (1 active study)
- Advanced Gastric Adenocarcinoma (1 active study)
- Advanced Gastroesophageal Junction Adenocarcinoma (1 active study)
Leading research sponsors in South Weymouth
- Alliance for Clinical Trials in Oncology
- Dana-Farber Cancer Institute
- NRG Oncology
- National Cancer Institute (NCI)
- Brigham and Women's Hospital
Frequently asked questions
How many paid clinical trials are currently recruiting in South Weymouth?
There are approximately 17 recruiting clinical trials in South Weymouth, Massachusetts listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in South Weymouth pay participants?
Most recruiting trials in South Weymouth compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in South Weymouth?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in South Weymouth?
The most common conditions under active study in South Weymouth include Breast Cancer (3), Stage IIIB Lung Cancer AJCC v8 (2), Triple Negative Breast Cancer (2), Advanced Esophageal Adenocarcinoma (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in South Weymouth?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in South Weymouth on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in South Weymouth?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in South Weymouth?
Recruiting research sites in South Weymouth include Dana-Farber/Brigham and Women's Cancer Center at South Shore, Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) in Clinical Affiliation with South Shore Hospital, DF/BWCC in Clinical Affiliation with South Shore Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in South Weymouth right now?
The largest active categories in South Weymouth are Cancer & tumors (16). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.